tiprankstipranks
Trending News
More News >
Rising Biosciences Inc (RBII)
OTHER OTC:RBII
US Market

Rising Biosciences (RBII) Ratios

Compare
20 Followers

Rising Biosciences Ratios

See a summary of RBII’s cash flow.
Ratios
Dec 20Dec 19
Liquidity Ratios
Current Ratio
<0.01
Quick Ratio
<0.01
Cash Ratio
<0.01
Solvency Ratio
-0.14
Operating Cash Flow Ratio
-0.04
Short-Term Operating Cash Flow Coverage
-0.06
Net Current Asset Value
$ ―$ -1.56M
Leverage Ratios
Debt-to-Assets Ratio
2.37
Debt-to-Equity Ratio
-0.82
Debt-to-Capital Ratio
-4.48
Long-Term Debt-to-Capital Ratio
0.00
Financial Leverage Ratio
-0.35
Debt Service Coverage Ratio
-0.14
Interest Coverage Ratio
-2.43
Debt to Market Cap
1.87
Interest Debt Per Share
<0.01
Net Debt to EBITDA
-6.49
Profitability Margins
Gross Profit Margin
-42.10%
EBIT Margin
-109.48%
EBITDA Margin
-89.01%
Operating Profit Margin
-109.48%
Pretax Profit Margin
-154.66%
Net Profit Margin
-154.66%
Continuous Operations Profit Margin
-154.66%
Net Income Per EBT
100.00%
EBT Per EBIT
141.27%
Return on Assets (ROA)
-63.30%
Return on Equity (ROE)
21.88%
Return on Capital Employed (ROCE)
15.49%
Return on Invested Capital (ROIC)
85.01%
Return on Tangible Assets
-63.30%
Earnings Yield
-50.02%
Efficiency Ratios
Receivables Turnover
0.00
Payables Turnover
4.78
Inventory Turnover
0.00
Fixed Asset Turnover
0.54
Asset Turnover
0.41
Working Capital Turnover Ratio
0.00
Cash Conversion Cycle
-76.39
Days of Sales Outstanding
0.00
Days of Inventory Outstanding
0.00
Days of Payables Outstanding
76.39
Operating Cycle
0.00
Cash Flow Ratios
Operating Cash Flow Per Share
>-0.01
Free Cash Flow Per Share
>-0.01
CapEx Per Share
<0.01
Free Cash Flow to Operating Cash Flow
2.37
Dividend Paid and CapEx Coverage Ratio
-0.73
Capital Expenditure Coverage Ratio
-0.73
Operating Cash Flow Coverage Ratio
-0.06
Operating Cash Flow to Sales Ratio
-0.36
Free Cash Flow Yield
-27.80%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-2.00
Price-to-Sales (P/S) Ratio
3.09
Price-to-Book (P/B) Ratio
-0.44
Price-to-Free Cash Flow (P/FCF) Ratio
-3.60
Price-to-Operating Cash Flow Ratio
-8.52
Price-to-Earnings Growth (PEG) Ratio
0.00
Price-to-Fair Value
-0.44
Enterprise Value Multiple
-9.96
Enterprise Value
1.45M
EV to EBITDA
-9.96
EV to Sales
8.87
EV to Free Cash Flow
-10.31
EV to Operating Cash Flow
-24.43
Tangible Book Value Per Share
>-0.01
Shareholders’ Equity Per Share
>-0.01
Tax and Other Ratios
Effective Tax Rate
>-0.01
Revenue Per Share
<0.01
Net Income Per Share
>-0.01
Tax Burden
1.00
Interest Burden
1.41
Research & Development to Revenue
0.00
SG&A to Revenue
0.00
Stock-Based Compensation to Revenue
0.00
Income Quality
0.23
Currency in USD